Search for: "SHIRE US INC."
Results 21 - 40
of 103
Sort by Relevance
|
Sort by Date
26 Dec 2017, 7:08 pm
Shire Pharmaceuticals LLC paid $350 million to resolve allegations that Shire and the company it acquired in 2011, Advanced BioHealing (ABH), induced clinics and physicians to use or overuse its bioengineered human skin substitute by offering lavish dinners, drinks, entertainment and travel; medical equipment and supplies; unwarranted payments for purported speaking engagements and bogus case studies; and cash, credits and rebates. [read post]
1 Dec 2017, 11:35 am
Paganini will complement OncoResponse, since OncoResponse has a strong focus on antibody cancer drugs and Paganini recently developed ONCR-201, a monoclonal antibody used in treating ovarian cancer.[29] Mallinckrodt PLC is expected to purchase Ocera Therapeutics Inc. in addition to its mid-stage hepatic encephalopathy, for about $42 million and to close in the fourth quarter of 2017. [read post]
24 Aug 2017, 5:32 pm
Shire US Holdings, Inc., C.A. [read post]
17 Jul 2017, 4:20 pm
Watson Pharmaceuticals, Inc. [read post]
13 Apr 2017, 9:44 am
Further, placing this burden on the patent owner differs from the traditional approach used during initial prosecution of a patent. [read post]
15 Feb 2017, 2:49 pm
Watson Pharmaceuticals, Inc., February 10, 2017, Hughes, T.). [read post]
10 Feb 2017, 9:54 am
Tell me why did Shire use “consisting of” instead of “comprising” or “consisting essentially of”? [read post]
5 Jan 2017, 11:37 am
Steward Carney Hospital, Inc. [read post]
5 Jan 2017, 11:37 am
Imperial Distributors, Inc., 15-P-966 (Rule 1:28 Decision) (Sept. 16, 2016), the Court affirmed the denial of an anti-SLAPP motion to dismiss an abuse of process counterclaim filed by defendant KLT Industries, Inc. after discovery. [read post]
5 Jan 2017, 11:37 am
Imperial Distributors, Inc., 15-P-966 (Rule 1:28 Decision) (Sept. 16, 2016), the Court affirmed the denial of an anti-SLAPP motion to dismiss an abuse of process counterclaim filed by defendant KLT Industries, Inc. after discovery. [read post]
25 Oct 2016, 9:28 pm
Shire Pharmaceuticals, Inc. [read post]
8 Jul 2016, 4:00 am
” (Shire Canada Inc. v. [read post]
17 May 2016, 5:06 am
Shire City Herbals, Inc. v. [read post]
12 Oct 2015, 12:22 am
However in a more recent challenge to US Patent 6773720B1, owned by Cosmo Technologies but licensed to Shire Pharmaceuticals, he has had a degree of success. [read post]
24 Sep 2015, 2:35 pm
Ivax Pharmaceuticals, Inc., 501 F.3d 1263 (Fed. [read post]
24 Sep 2015, 11:31 am
Shire contends that on the facts before us“Forest cannot be distinguished. [read post]
5 Sep 2015, 11:58 am
A different three-judge panel on Sept. 1 said information of a clinical trial wasn’t evidence that could be used to challenge Biogen Inc. [read post]
8 Jul 2015, 8:31 am
See e.g., Shire U.S. [read post]
4 Jun 2015, 7:25 am
No infringement because of estoppel and invalidity through lack of enablement.CAFC in Shire v. [read post]
23 Dec 2014, 6:10 pm
Circuit Attorney KBR Privilege Case (workers-compensation.blogspot.com)US Sues KBR for Kickbacks and False Claims Relating to Iraq Support Services Contract (burnpitclaims.blogspot.com)Public Disclosures Don't Bar Halliburton FCA Suit, Court Says (workers-compensation.blogspot.com)Medical Device Litigation: Medtronic, Inc. v. [read post]
